ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

TargetBeta

PARP1

poly(ADP-ribose) polymerase 1 · also PARP, ARTD1, Poly-PARP, PARS · Zinc fingers PARP-type

10 programs in company-led studies act on PARP1, from 8 companies: 1 in phase 3, 2 approved with new studies. Each with where its target was read from.

Programs

Furthest phase first. A target read by rule is marked rule (8 of them); the others are the company’s own words or a reading by Claude, each quoted on the program’s page.

ProgramCompanyActs asFurthest phaseStudiesAlso acts onRead from
olaparibruleAstraZenecainhibitorphase 47823 runningPARP2, PARP3ChEMBL
niraparibruleGlaxoSmithKlineinhibitorphase 44310 runningPARP2ChEMBL
saruparibruleAstraZenecainhibitorphase 31411 runningPARP2the studies' text
nesuparibruleJeil Pharmaceuticalinhibitorphase 243 runningPARP2, TANK, TNKSNCIt
palacaparibAstraZenecainhibitorphase 233 running–a judged reading
senaparibruleImpact Therapeuticsinhibitorphase 2120 runningPARP2ChEMBL
PARP1 Inhibitor HS-10502ruleHansoh Pharmaceutical Groupinhibitorphase 122 running–the studies' text
DM5167ruleDIGMBIOinhibitorphase 111 running–the studies' text
HSK46256ruleHaisco Pharmaceutical Groupinhibitorphase 111 running–the studies' text
TQB3122Sino Biopharmaceuticalinhibitorphase 111 running–the company's pipeline

Also acted on by the same programs

Conditions their studies are in

Primary completions ahead

Each program’s next study to reach its primary completion, by the sponsor’s estimate.

What this can’t show

  • Only programs whose target has been read: most early programs are named only by a code and their companies do not say what they act on.
  • A target read by rule can be wrong; each program’s page quotes the words it was read from.
  • “Acts as” is read from the words its target was read from — agonist, antagonist, inhibitor, lowers it (an siRNA or antisense drug), degrader — and is a dash where they do not say, or say two things; an antibody that only “binds” says neither.
  • Programs in company-led studies on ClinicalTrials.gov with a study in the last two years; academic studies and other registries are not counted here.